Alpha Cognition (ACOG) Revenue (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Revenue of $2.8 million for Q4 2025, down 1.68% quarter-over-quarter from $2.8 million in Q3 2025.

Alpha Cognition (ACOG) Revenue (2025 - 2026) Analysis & Trends

Alpha Cognition's Revenue history runs 1 years deep, the most recent figure standing at $2.8 million for Q4 2025.

In Q4 2025, Revenue changed N/A year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $10.2 million (changed N/A YoY), while the FY2025 annual figure was $10.2 million, changed N/A from the prior year.
Revenue for Q4 2025 stood at $2.8 million, down from $2.8 million in the prior quarter.
The five-year high for Revenue was $2.9 million in Q1 2025, with the low at $1.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	139.77 Bn	131.91 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	86.74 Bn	78.75 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	65.36 Bn	60.17 Bn	1.37 Bn	1.52 Bn
4	Moderna	59.60 Bn	54.47 Bn	52.00 Mn	145.00 Mn
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn	1.71 Bn
6	Alnylam Pharmaceuticals	31.80 Bn	28.49 Bn	992.69 Mn	1.29 Bn
7	BioNTech SE	28.13 Bn	9.73 Bn	668.28 Mn	1.06 Bn
8	Insmed	27.54 Bn	26.38 Bn	358.27 Mn	425.49 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	674.14 Mn
10	Alpha Cognition	208.16 Mn	166.72 Mn	5.70 Mn	6.09 Mn

Download Data